This page shows the latest Syndesi Therapeutics news and features for those working in and with pharma, biotech and healthcare.
AbbVie has announced its acquisition of Syndesi Therapeutics, further expanding AbbVie’s neuroscience portfolio. ... The acquisition further reinforces AbbVie’s neurology pipeline, as four years ago, Syndesi Therapeutics gained the rights to UCB’s
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
No results were found
Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...